IMMUTEP LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Sep) $82,528,400 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (7-Sep) 31,257,153 (2.12%) (149th) |
|
52w High $0.470 |
52w Low $0.028 |
P/E 7.20 |
EPS -0.05 |
[ARTICLE] Small cap biotech Immutep soars 10.5pc on Merck deal
A news article has been posted about Immutep on the AFR. The article was published around , on 16 March 2021 at 5:43pm.
Immutep has signed another deal with Merck to test its immunotherapy drug alongside Merck’s multibillion dollar therapy Keytruda.
Read ArticleIMM was $0.37 at the close of trade on 16 March 2021
Find all articles about Immutep, including others on the AFR, on the media page.
You must be logged in to post a reply.